Skip to main content
. Author manuscript; available in PMC: 2010 Jun 28.
Published in final edited form as: Behav Pharmacol. 2009 Mar;20(2):174–183. doi: 10.1097/FBP.0b013e32832a8f43

Fig. 7.

Fig. 7

Mean ±SEM free-running period lengths of wild-type (+/ +) and heterozygote (+ /−) Gsk3β knockout mice. Different letters above bars denote significant differences between groups (P<0.05). The τ of Gsk3β+/− mice during weeks 6 and 7 of methamphetamine (MAP) treatment were highly variable and the mean did not differ significantly from any other group.